UW-Madison School of Medicine and Public Health
Amy Schultz, PhD, Senior Scientist in the Department of Population Health Sciences, has received an R01 research grant from the National Institute of Environmental Health Sciences for the project, Examining pathways of PFAS exposure and their impacts on hyperlipidemia in a rural community impacted by land spreading. The study will examine per- and polyfluoroalkyl substances (PFAS) …
ADSI is a landmark research effort using large-scale data and innovative methods to understand autism. Amy Cochran leads the study: Understanding causes of autism, its heterogeneity and rising prevalence with emerging methods in causal inference, a project that examines factors contributing to autism risk, variation in presentation, and increasing prevalence.
The study is led by Dr. Michael Pulia, associate professor and director of the Emergency Care for Infectious Diseases research program in the BerbeeWalsh Department of Emergency Medicine will examine underrecognized factors that may contribute to pneumonia in older adults — including changes in oral health and impaired swallowing due to aging and bacteria that normally live in …
You can access NY Times through your UW academic pass here. Story can be found here: https://www.nytimes.com/2026/07/10/well/tick-borne-disease-risks-regions.html?unlocked_article_code=1.wlA.R62G.HwRDO70mdKzV&smid=url-share
Congratulations to Zoe Walts, PHS Epidemiology PhD candidate, for winning the WI Initiative for Science Literacy Award. Her thesis chapter titled, “The Contribution of Allostatic Load to Colorectal Cancer Outcomes.” Please review her submission here.
Title: Promoting Use of a National Hotline to Reduce Overdose Deaths in Wisconsin Drug overdose remains the leading cause of preventable death among U.S. adults aged 25-44. The majority of overdose deaths occur deaths occur during solitary drug use, when no bystanders are available to respond with lifesaving interventions like naloxone or rescue breaths. The objective …
Title: Advancing statistical genetics tools for reliable drug target discovery and treatment optimization This program aims to develop and apply advanced statistical genetics tools to address key methodological challenges in identifying the potential causal effects of circulating molecules on complex diseases. By strengthening causal inference, these innovations will accelerate the discovery of novel drug targets, optimize …